| Patents for A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy (86,964) |
|---|
| 09/03/2014 | EP2771036A2 Cystic fibrosis treatment |
| 09/03/2014 | EP2771035A1 Improved hcv vaccines and methods for using the same |
| 09/02/2014 | US8822669 miRNA expression vector |
| 09/02/2014 | US8822667 Nucleic acid molecule capable of binding to c-Met and use thereof |
| 09/02/2014 | US8822405 Uses of mammalian cytokines and agonists; related reagents |
| 09/02/2014 | US8822223 Mature dendritic cell compositions and methods for culturing same |
| 09/02/2014 | US8822169 HMG1 antibody for treating inflammatory conditions |
| 09/02/2014 | US8821890 Influenza virus vaccine composition and methods of use |
| 09/02/2014 | US8821859 Methods and articles for the delivery of therapeutic agents |
| 08/28/2014 | WO2013016434A8 Compositions and methods of treating head and neck cancer |
| 08/28/2014 | US20140243397 Cxcr4 inhibiting carriers for nucleic acid delivery |
| 08/28/2014 | US20140243391 Phospholipid-detergent conjugates and uses thereof |
| 08/28/2014 | US20140242192 Clusterin Antisense Therapy for Treatment of Cancer |
| 08/28/2014 | US20140242106 Staphylococcus aureus proteins and nucleic acids |
| 08/28/2014 | US20140242031 Adeno-Associated Virus Virions with Variant Capsid and Methods of Use Thereof |
| 08/27/2014 | EP2770054A1 Activation of functional nucleic acid by specific modification |
| 08/27/2014 | EP2768519A2 Antigen presenting cancer vaccine with gamma interferon |
| 08/26/2014 | US8815826 Targeting microRNAs for the treatment of fibrosis |
| 08/26/2014 | US8815824 Compositions and methods for treating tumors, fibrosis, and pulmonary alveolar proteinosis |
| 08/26/2014 | US8815823 Pharmaceutical compositions and methods useful for modulating angiogenesis, inhibiting metastasis and tumor fibrosis, and assessing the malignancy of colon cancer tumors |
| 08/26/2014 | US8815821 Double-stranded oligonucleotides |
| 08/26/2014 | US8815820 Anti viral therapy |
| 08/26/2014 | US8815599 Methods and compositions for the inhibition of gene expression |
| 08/26/2014 | US8815563 Modified virus |
| 08/26/2014 | US8815505 Use of regulatory sequences for specific, transient expression in neuronal determined cells |
| 08/26/2014 | US8815249 Ii-key/antigenic epitope hybrid peptide vaccines |
| 08/26/2014 | US8815238 Methods for Preparing TACI-immunoglobulin fusion proteins |
| 08/26/2014 | CA2761105C Phage lambda display constructs |
| 08/26/2014 | CA2580126C Oligoribonucleotides and methods of use thereof for treatment of alopecia, acute renal failure and other diseases |
| 08/26/2014 | CA2390344C 85kda neisserial antigen |
| 08/21/2014 | WO2014127378A2 Design of short oligonucleotides as vaccine adjuvants and therapeutic agents |
| 08/21/2014 | WO2014127268A2 Modulation of apolipoprotein c-iii (apociii) expression in lipoprotein lipase deficient (lpld) populations |
| 08/21/2014 | WO2014127261A1 Chimeric antigen receptor and methods of use thereof |
| 08/21/2014 | WO2014127196A1 Aav8 retinoschisin expression vector for treating x-linked retinoschisis |
| 08/21/2014 | WO2014126796A2 Methods of diagnosing, treating and monitoring diabetic retinopathy |
| 08/21/2014 | WO2014125291A1 Agents which induce lymphangiogenesis for use in the treatment of cystic kidney disease |
| 08/21/2014 | US20140234400 Targeted Lipid-Drug Formulations for Delivery of Drugs to Myeloid and Lymphoid Immune Cells |
| 08/21/2014 | US20140234361 Novel expression vectors and uses thereof |
| 08/21/2014 | US20140234299 Therapies for chronic renal failure using one or more integrin antagonists |
| 08/21/2014 | US20140234285 Method for Therapeutic Angiogenesis |
| 08/21/2014 | US20140234274 Directed Evolution and In Vitro Panning of Virus Vectors |
| 08/21/2014 | DE10066235C5 Verfahren und Medikament zur Hemmung der Expression eines vorgegebenen Gens Method and medicament for the inhibition of expression of a given gene |
| 08/20/2014 | EP2766047A1 Methods |
| 08/20/2014 | EP2766045A2 Treatment of breast cancer with companion diagnostic |
| 08/20/2014 | EP2765997A2 Porous nanoparticle-supported lipid bilayers (protocells) for targeted delivery including transdermal delivery of cargo and methods thereof |
| 08/19/2014 | US8809516 Therapeutic compositions |
| 08/19/2014 | US8809515 Methods and compositions for the specific inhibition of gene expression by double-stranded RNA |
| 08/19/2014 | US8809297 Anticancer composition |
| 08/19/2014 | US8809294 Method of inhibiting miR-33 using a modified oligonucleotide |
| 08/19/2014 | US8809293 Compositions and methods for inhibiting gene expression of hepatitis B virus |
| 08/19/2014 | US8809292 Compositions and methods for inhibiting expression of the PCSK9 gene |
| 08/19/2014 | US8809291 Id-1 gene and gene products as therapeutic targets for treatment of breast cancer and other types of carcinoma |
| 08/19/2014 | US8809290 Methods and compositions to generate and control the effector profile of T cells by simultaneous loading and activation of selected subsets of antigen presenting cells |
| 08/19/2014 | US8809288 Method for increasing immunoreactivity |
| 08/19/2014 | US8809287 Compositions and methods for altering Wnt autocrine signaling |
| 08/19/2014 | US8809058 Helper virus-free AAV production |
| 08/19/2014 | US8809011 HIFα hydroxylation assay |
| 08/19/2014 | US8808684 Epidermal growth factor receptor (EGFR) and methods of use in adenoviral-associated virus type 6 (AAV6) transduction |
| 08/19/2014 | CA2545435C Hydroxy piperidine derivatives to treat gaucher disease |
| 08/19/2014 | CA2482718C Derivatives of the il-2 receptor gamma chain, their production and use |
| 08/19/2014 | CA2411596C Therapeutic agents - ii |
| 08/19/2014 | CA2375106C Compositions and methods for the therapeutic use of an atonal-associated sequence for deafness, osteoarthritis, and abnormal cell proliferation |
| 08/19/2014 | CA2364492C Regulatory constructs comprising intron 3 of prostate specific membrane antigen gene |
| 08/14/2014 | WO2014124433A1 5'-triphosphate oligoribonucleotides |
| 08/14/2014 | WO2014124143A1 Modified t lymphocytes having improved specificity |
| 08/14/2014 | WO2014123935A1 Biodegradable and clinically-compatible nanop articles as drug delivery carriers |
| 08/14/2014 | WO2014122648A1 Positively charged polysaccharides for rna transfection |
| 08/14/2014 | WO2014121758A1 Human hepatocyte-like cells and uses thereof |
| 08/14/2014 | WO2014096418A3 Micrornas as therapeutics and biomarkers for epilepsy |
| 08/14/2014 | US20140228289 Modified and stabilized gdf propeptides and uses thereof |
| 08/14/2014 | US20140227778 MicroRNA and Methods for Inhibiting Same |
| 08/14/2014 | US20140227278 Antibodies to human signal peptide-containing proteins |
| 08/14/2014 | US20140227226 Infectivity-enhanced conditionally-replicative adenovirus and uses thereof |
| 08/14/2014 | US20140227182 Cancer imaging with therapy: theranostics |
| 08/13/2014 | EP2763703A2 Control of whole body energy homeostasis by microrna regulation |
| 08/13/2014 | EP2763702A1 TREATMENT OF OBESITY AND OBESITY-RELATED DISORDERS BY PHARMACOLOGICAL TARGETING OF Kv1.3 POTASSIUM CHANNELS |
| 08/13/2014 | EP2763701A1 Modified nucleosides, nucleotides, and nucleic acids, and uses thereof |
| 08/13/2014 | EP2763693A2 Blood coagulation factor and a derivatives, conjugates and complexes comprising the same, and use thereof |
| 08/13/2014 | EP2763692A2 Use of igf-1 in the modulation of treg cell activity and the treatment and prevention of autoimmune disorders or diseases |
| 08/13/2014 | CN103987842A 治疗癌症的方法 Methods of treating cancer |
| 08/13/2014 | CN103987408A 通过药理学靶向Kv1.3钾通道治疗肥胖和肥胖相关病症 Kv1.3 potassium channel targeting the treatment of obesity and obesity-related disorders by pharmacological |
| 08/13/2014 | CN103981192A 表达山羊α干扰素的重组腺病毒及其构建方法和应用 Goat α-interferon expression adenovirus and its construction method and application |
| 08/13/2014 | CN103981155A 靶向肝癌溶瘤腺病毒的构建法和应用 Build targeted oncolytic adenovirus liver law and application |
| 08/13/2014 | CN103977423A 一种三角板形核酸纳米制剂及制备方法和应用 One kind of triangle-shaped nano-formulations of nucleic acid preparation method and application |
| 08/13/2014 | CN103977422A 胍类降糖药-多糖共轭物及其制备方法和用途 Guanidine hypoglycemic agents - polysaccharide conjugates and their preparation and use |
| 08/13/2014 | CN103977403A 治疗溶血性疾病的方法 A method of treating a hemolytic disease |
| 08/13/2014 | CN103977402A 治疗溶血性疾病的方法 A method of treating a hemolytic disease |
| 08/13/2014 | CN103251960B 用于预防人或动物慢性弓形虫病的dna疫苗 Dna vaccine for the prevention of human or animal chronic toxoplasmosis |
| 08/13/2014 | CN103157113B 用于哮喘预防和免疫治疗的嵌合型DNA疫苗Hsp70/CD80 Prevention and treatment of asthma, for the chimeric DNA immunization vaccine Hsp70 / CD80 |
| 08/13/2014 | CN103088063B 一种表达狂犬病病毒g蛋白的重组假型杆状病毒及应用 A recombinant baculovirus and application pseudotyped rabies virus g protein expression |
| 08/13/2014 | CN103088028B 一种沉默人乳腺癌特异基因的shRNA A shRNA silencing specific genes in human breast cancer |
| 08/13/2014 | CN102776188B 靶向raf1抗乙脑病毒寡核苷酸的结构和用途 Targeting raf1 anti-JE virus oligonucleotide structure and purpose |
| 08/13/2014 | CN102746387B 一种hcv的dna疫苗及其制备方法 One kind of dna hcv vaccine and its preparation method |
| 08/13/2014 | CN102660579B HBx和人IL-12双基因重组载体及抗肝癌疫苗 HBx and human IL-12 Double Gene recombinant vector vaccines and anti-hepatoma |
| 08/13/2014 | CN102258778B 生物分子表面展示及其用途 Biomolecular surface display and its use |
| 08/13/2014 | CN101928344B 抗cd20的人单克隆抗体 The human monoclonal antibody anti-cd20 |
| 08/13/2014 | CN101735383B 聚甲基丙烯酸二甲胺基乙酯-聚甲基丙烯酸盐包裹氧化锌量子点及制备和应用 Polymethyl methacrylate dimethyl amino ethyl acrylate - methyl acrylate poly wrapped zinc oxide and preparation and application of quantum dots |
| 08/13/2014 | CN101698852B 具有cd137l功能的蛋白或多肽及其基因和应用 Protein or polypeptide and gene functions and applications with cd137l |
| 08/12/2014 | US8802920 Acellular tissue matrices made from α-1,3-galactose-deficient tissue |
| 08/12/2014 | US8802773 In vivo polynucleotide delivery conjugates having enzyme sensitive linkages |